BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 31743877)

  • 1. An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ).
    Shenghua P; Ziqin Z; Shuyu T; Huixia Z; Xianglu R; Jiao G
    Biomed Pharmacother; 2020 Jan; 121():109421. PubMed ID: 31743877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota combined with metabolomics reveals the metabolic profile of the normal aging process and the anti-aging effect of FuFang Zhenshu TiaoZhi(FTZ) in mice.
    Luo D; Chen K; Li J; Fang Z; Pang H; Yin Y; Rong X; Guo J
    Biomed Pharmacother; 2020 Jan; 121():109550. PubMed ID: 31704617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted Metabolomics Reveals the Protective Effect of Fufang Zhenshu Tiaozhi (FTZ) on Aging-Induced Osteoporosis in Mice.
    Luo D; Li J; Chen K; Rong X; Guo J
    Front Pharmacol; 2018; 9():1483. PubMed ID: 30670964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on Metabolic Trajectory of Liver Aging and the Effect of Fufang Zhenzhu Tiaozhi on Aging Mice.
    Luo D; Li J; Chen K; Yin Y; Fang Z; Pang H; Rong X; Guo J
    Front Pharmacol; 2019; 10():926. PubMed ID: 31555127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gancao-Gansui combination impacts gut microbiota diversity and related metabolic functions.
    Yu J; Guo J; Tao W; Liu P; Shang E; Zhu Z; Fan X; Shen J; Hua Y; Zhu KY; Tang Y; Duan JA
    J Ethnopharmacol; 2018 Mar; 214():71-82. PubMed ID: 29198875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.
    Qu W; Liu S; Zhang W; Zhu H; Tao Q; Wang H; Yan H
    Food Funct; 2019 Sep; 10(9):5886-5897. PubMed ID: 31464319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect and mechanism of Jingfang Granules on acute lung injury based on intestinal flora and fecal metabolomics].
    Xiao H; Sun XX; Sun CH; Wang EL; Wang XZ; Yao JC
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1915-1923. PubMed ID: 38812204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
    Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification effects of SanWei GanJiang Powder on liver and intestinal damage through reversing bile acid homeostasis.
    Li N; Wang B; Wu Y; Luo X; Chen Z; Sang C; Xiong T
    Biomed Pharmacother; 2019 Aug; 116():109044. PubMed ID: 31174088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupleuri radix extract ameliorates impaired lipid metabolism in high-fat diet-induced obese mice via gut microbia-mediated regulation of FGF21 signaling pathway.
    Wu L; Yan Q; Chen F; Cao C; Wang S
    Biomed Pharmacother; 2021 Mar; 135():111187. PubMed ID: 33556916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-kappaB and inflammatory factors in rabbits.
    Zhang R; Li T; Guo J; Zhao Y; Liu Y; Yao Y; Zeng Z
    Lipids Health Dis; 2018 Nov; 17(1):272. PubMed ID: 30497486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism.
    Liu J; Yue S; Yang Z; Feng W; Meng X; Wang A; Peng C; Wang C; Yan D
    Pharmacol Res; 2018 Aug; 134():40-50. PubMed ID: 29787870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques.
    Shao X; Zeng W; Wang Q; Liu S; Guo Q; Luo D; Luo Q; Wang D; Wang L; Zhang Y; Diao H; Piao S; Yan M; Guo J
    J Ethnopharmacol; 2024 Apr; 324():117705. PubMed ID: 38219878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats.
    Yu M; Jia HM; Zhou C; Yang Y; Sun LL; Zou ZM
    Sci Rep; 2017 Apr; 7():46551. PubMed ID: 28425490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome-Metabolomics Analysis of the Impacts of Long-Term Dietary Advanced-Glycation-End-Product Consumption on C57BL/6 Mouse Fecal Microbiota and Metabolites.
    Qu W; Nie C; Zhao J; Ou X; Zhang Y; Yang S; Bai X; Wang Y; Wang J; Li J
    J Agric Food Chem; 2018 Aug; 66(33):8864-8875. PubMed ID: 30037223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota-related metabolite alpha-linolenic acid mitigates intestinal inflammation induced by oral infection with Toxoplasma gondii.
    Yang J; Liu S; Zhao Q; Li X; Jiang K
    Microbiome; 2023 Dec; 11(1):273. PubMed ID: 38087373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the protective effects of Yin-Chen-Hao Tang against acute liver injury induced by carbon tetrachloride using 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Liu F; Sun Z; Hu P; Tian Q; Xu Z; Li Z; Tian X; Chen M; Huang C
    J Pharm Biomed Anal; 2019 Sep; 174():567-577. PubMed ID: 31261038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the major metabolites of hyperoside produced by the human intestinal bacteria using the ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Yang J; Qian D; Guo J; Jiang S; Shang EX; Duan JA; Xu J
    J Ethnopharmacol; 2013 May; 147(1):174-9. PubMed ID: 23458919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.